not a scientist here but a few question regarding the heart protection.
Is it possible that without the use of Zantrene the FTO barrier is still in place therefore the chemo drugs do more damage to other organs such as the heart, (im picturing chemo trying to enter a protected or hidden cancer cell then bouncing of to other areas of the body that have less resistance). But when Zantrene is used the FTO components are removed or weakened allowing chemo drugs to attack the cancer instead of the heart?
If this is correct would this mean that heart protection is another bonus of FTO treatment via Zantrene?
happy new year RAC punters, it will be one of the most interesting years that the stock market will see good and bad. by the end of 2022 RAC will have some extra digits on its price.
Ann: Expanded Heart Protection Discovery for Zantrene, page-302
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |